OTC Zantac prevention claim for heartburn, dyspepsia, indigestion proposed in U.K..
This article was originally published in The Tan Sheet
Executive Summary
RANITIDINE OTC TO GAIN HEARTBURN PREVENTION INDICATION IN U.K., according to the Medicines Control Agency's twice-yearly consultation letter on proposals to amend the prescription-only medicines order, released July 24. "Ranitidine has been available as a pharmacy medicine for the short-term symptomatic relief of heartburn, dyspepsia, indigestion, acid indigestion and hyperacidity since 1994," the letter states. "In line with the [Committee on Safety of Medicines'] previous decisions on such substances, we propose to extend the availability of ranitidine as a pharmacy medicine for the prevention of these symptoms when consuming food or drink." Pharmacy medicines are sold behind-the-counter in the U.K.